Corrigendum to “Blockade of STAT3 activation by sorafenib derivatives through enhancing SHP-1 phosphatase activity” (Eur. J. Med. Chem. (2012) 55 (220–227)(S0223523412004497)(10.1016/j.ejmech.2012.07.023))
Journal
European Journal of Medicinal Chemistry
Journal Volume
143
Date Issued
2018
Author(s)
Abstract
The authors regret for the mistake occurred in Figure 6B. The corrected figure is shown below. The result and conclusions in the article remain unchanged. The authors would like to apologise for any inconvenience caused.
SDGs
Publisher
Elsevier Masson SAS
Type
corrigendum